Acasti Pharma Inc., a Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT)
subsidiary, announces a clinical study update and announces the first ever
human data of safety and efficacy of its patented prescription drug...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.